| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Division of Cardiovascular Diseases, Department of Internal Medicine and Pharmacology, Mayo Clinic, Mayo Foundation, Rochester, Minnesota 55905, USA
1Correspondence: Guggenheim 70l, 200 First St., SW, Mayo Clinic, Rochester MN 55904, USA. E-mail: terzic.andre{at}mayo.edu
Mutations in genes encoding ion channels have increasingly been identified to cause disease conditions collectively termed channelopathies. Recognizing the molecular basis of an ion channel disease has provided new opportunities for screening, early diagnosis, and therapy of such conditions. This synopsis provides an overview of progress in the identification of molecular defects in inwardly rectifying potassium (Kir) channels. Structurally and functionally distinct from other channel families, Kir channels are ubiquitously expressed and serve functions as diverse as regulation of resting membrane potential, maintenance of K+ homeostasis, control of heart rate, and hormone secretion. In humans, persistent hyperinsulinemic hypoglycemia of infancy, a disorder affecting the function of pancreatic ß cells, and Bartter's syndrome, characterized by hypokalemic alkalosis, hypercalciuria, increased serum aldosterone, and plasma renin activity, are the two major diseases linked so far to mutations in a Kir channel or associated protein. In addition, the weaver phenotype, a neurological disorder in mice, has also been associated with mutations in a Kir channel subtype. Further genetic linkage analysis and full understanding of the consequence that a defect in a Kir channel would have on disease pathogenesis are among the priorities in this emerging field of molecular medicine.—Abraham, M. R., Jahangir, A., Alekseev, A. E., Terzic, A. Channelopathies of inwardly rectifying potassium channels.
Key Words: ion channel disease • persistent hyperinsulinemic hypoglycemia of infancy • Bartter's syndrome • weaver phenotype
This article has been cited by other articles:
|
|
 |
|
  D. E. Logothetis, D. Lupyan, and A. Rosenhouse-Dantsker Diverse Kir modulators act in close proximity to residues implicated in phosphoinositide binding J. Physiol., August 1, 2007; 582(3): 953 - 965. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. H. Yu and W. A. Catterall The VGL-Chanome: A Protein Superfamily Specialized for Electrical Signaling and Ionic Homeostasis Sci. Signal., October 5, 2004; 2004(253): re15 - re15. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-M. Cha, P. P. Dzeja, W. K. Shen, A. Jahangir, C. Y. T. Hart, A. Terzic, and M. M. Redfield Failing atrial myocardium: energetic deficits accompany structural remodeling and electrical instability Am J Physiol Heart Circ Physiol, April 1, 2003; 284 (4): H1313 - H1320. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. R. Abraham, V. A. Selivanov, D. M. Hodgson, D. Pucar, L. V. Zingman, B. Wieringa, P. P. Dzeja, A. E. Alekseev, and A. Terzic Coupling of Cell Energetics with Membrane Metabolic Sensing. INTEGRATIVE SIGNALING THROUGH CREATINE KINASE PHOSPHOTRANSFER DISRUPTED BY M-CK GENE KNOCK-OUT J. Biol. Chem., June 28, 2002; 277(27): 24427 - 24434. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. V. Zingman, D. M. Hodgson, M. Bienengraeber, A. B. Karger, E. C. Kathmann, A. E. Alekseev, and A. Terzic Tandem Function of Nucleotide Binding Domains Confers Competence to Sulfonylurea Receptor in Gating ATP-sensitive K+ Channels J. Biol. Chem., April 12, 2002; 277(16): 14206 - 14210. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. BIENENGRAEBER, A. E. ALEKSEEV, M. R. ABRAHAM, A. J. CARRASCO, C. MOREAU, M. VIVAUDOU, P. P. DZEJA, and A. TERZIC ATPase activity of the sulfonylurea receptor: a catalytic function for the KATP channel complex FASEB J, October 1, 2000; 14(13): 1943 - 1952. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
